UK: Lower prices for LNG EC
June 2017. On June 23rd President Andrzej Duda finally signed the bill proposed by the ruling party Law and Justice (PiS), which will change the status of the only EC pill currently available without prescription in Poland (EC with ulipristal acetate, sold under the brand name ellaOne). The so called “Act of 25th May 2017…
December 2024. The marketing authorisation for Esmya was withdrawn in July from the European Economic Area and Belarus, Moldova, Serbia, Ukraine and the United Kingdom, at the request of the marketing-authorisation holder. (See announcement on the European’s Medicines Agency’s website here). The withdrawal was due to commercial reasons and there is no change in the safety…
The Faculty of Sexual and Reproductive Healthcare (FSRH) of the United Kingdom recently released a new guideline on emergency contraception. This new guideline, which includes recommendations on LNG and UPA EC pills as well as on the use of IUD for EC, has been developed by the FSRH and brings together evidence and expert opinion…
September 2026. The World Health Organization (WHO) launches its new Guideline on Expanding Contraceptive Options (ECO), providing evidence-based recommendations on emerging contraceptive methods and service delivery practices. The guideline responds to requests from Member States and partners for guidance on contraceptive methods not yet included in the Medical eligibility criteria for contraceptive use (MEC), as…
December 2021. Last week, a big retail pharmacy chain in the United Kingdom announced a 50% discount on emergency contraception pills during Black Friday. The promotion has raised strong criticism from a number of organisations and Members of Parliament, who point out that essential women’s health products should not be used to make a profit. MPs and…

March 2025. A new article describes uses of ulipristal acetate (UPA) beyond emergency contraception: Uses of ulipristal acetate beyond emergency contraception: a narrative review (Ebersole, Ashley M. et al. Contraception). The review describes the extensive potential for UPA to treat and/or prevent conditions such as fibroids, breast cancer, and abnormal uterine bleeding, in addition to other…
Menú